Why do meningiomas recur?

Journal of Neurosurgical Sciences

Volumn 47, Issue 2, 2003, Pages 65-68

  Palma, L ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURGERY; EDITORIAL; MENINGIOMA; NEURORADIOLOGY; TUMOR RECURRENCE;

HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM RECURRENCE, LOCAL;

EID: 0344664512     PISSN: 00264881     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (41)

1. Cushing H, Eisenhardt L. Meningiomas, their classification, regional behavoir, life history, and surgical end results. Springfield: Charles C. Thomas; 1938.
2. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20:22-39.
3. Cantore G, Delfini R, Domenicucci M. Recurrence of intracranial meningioma. In: Schmidek HH, editor. Meningiomas and their surgical management. Philadelphia, London, Toronto: Saunders; 1991.p.526-34.
4. Jääskeläinen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 1986;26:461-9.
5. Borovich B, Doron Y. Recurrence of intracranial meningiomas: the role plaied by regional multicentricity. J Neurosurg 1986;64:58-63.
6. Borovich B, Doron Y, Brami J, Guilburg JN, Zaaroor M, Goldsher D et al. Recurrence of intracranial meningiomas: the role played by regional multicentricity. Part 2: clinical and radiological aspects. J Neurosurg 1986;65:168-71.
7. Kinjo T, Al-Mefty O, Kanaan I. Grade zero removal of supretentorial convexity meningiomas. Neurosurgery 1993;33:394-9.
8. Aoki S, Sasaki Y, Machida T, Tanioka H. Contrast-enhanced MR imaging in patient with meningioma: importance of enhancement of the dura adjacent to tumor. AJNR 1990;11:935-8.
9. Goldsher D, Litt AW, Pinto RS, Bannon KR, Kricheff IV. Dural "tail" associated with meningiomas on Gd-DTPA-enhanced MR images: characteristics, differential diagnostic value, possible implications for treatment. Radiology 1990;176:447-50.
10. Larson JJ, Tew JM Jr, Wiot JG, de Courten GM. Association of meningiomas with dural "tails": surgical significance. Acta Neurochir 1992;114:59-63.
11. Nägele T, Petersen D, Klose U, Grodd W, Opitz H, Voigt K. The "dural tail" adjacent to meningiomas studied by dynamic contrast-enhanced MRI: a comparison with histopathology. Neuroradiology 1994;36:303-7.
12. Wilms G, Lammens M, Marchal G, Calenbergh FV, Plets C, Fraeyenhoven LV et al. Thickening of dura surrounding meningiomas: MR features. J Comput Assist Tomogr 1989;13:763-8.
13. Nakau H, Miyazawa T, Tamai S, Tsuchiya K, Shima K, Shirotani T et al. Pathologic significance of meningeal enhancement ("flare sign") of meningiomas on MRI. Surg Neurol 1997;48:584-91.
14. Sasaki K, Tada T, Fukasaku K, Kyoshima K, Kobayashi S. Histological examination of gadolinium-enhanced dura mater around meningiomas on magnetic resonance imaging. Neurol Med Chir 1993;33:429-33.
15. Sekiya T, Manabe H, Iwabuchi T, Narita T. The dura mater adjacent to the attachment of meningiomas: its enhanced MR imaging and histological findings. Neurol Surg 1992;20:1063-8.
16. Tokumaru A, O'uchi T, Eguchi T, Kawamoto S, Kokubo T, Suzuki M et al. Prominent meningeal enhancement adjacent to meningioma on Gd-DTPA-enhanced MR images: histopathologic correlation. Radiology 1990;175:431-3.
17. Bitzer M, Wöckel L, Morgalla M, Keller C, Friese S, Heiss E et al. Peritumoral brain oedema in intracranial meningiomas: influence of tumor size, location and histology. Acta Neurochir (Wien) 1997;139:1136-42.
18. Go KG, Wilmink JT, Molenaar WM. Peritumoral oedema associated with meningiomas. Neurosurgery 1988;23:175-9.
19. Ide M, Jimbo M, Kubo O, Yamamoto M, Takeyama E, Imanaga H. Peritumoral brain oedema and cortical damage by meningiomas. Acta Neurochir (Suppl) 1994;60:369-72.
20. Nakasu S, Nakasu Y, Nakajima M, Matsuda M, Handa J. Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg 1999;90:455-62.
21. Nakasu S, Nakasu Y, Matsumura K, Matsuda M, Handa J. Interface between the meningioma and the brain on magnetic resonance imaging. Surg Neurol 1990;33:105-16.
22. Ohno K, Matsushima Y, Aoyagi M, Ikeda J, Suzuki R, Ichimura K et al. Peritumoral cerebral edema in meningiomas: the role of the tumor-brain interface. Clin Neurol Neurosurg 1992;94:291-5.
23. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse C. Meningioma grading. An analysis of histologic parameters. Am J Surg Pathol 1997;21:1455-65.
24. Salpietro FM, Alafaci C, Lucerna S, Iacopino D, Todaro C, Tomasello F. Peritumoral oedema in meningiomas: microsurgical observations of different brain tumor interfaces related to computed tomography. Neurosurgery 1994;35:638-42.
25. Sindou MP, Alaywan M. Most intracranial meningiomas are not cleavable tumors: anatomic-surgical evidence and angiographic predictibility. Neurosurgery 1998;42:476-80.
26. Crompton MR, Gautier-Smith PC. The prediction of recurrence in meningiomas. J Neurol Neurosurg Psychiatry 1970;33:80-7.
27. Go KG, Kamman RL, Wilmink JT, Mooyart EL. A study or peritumoral brain oedema around meningiomas by CT and MRI scanning. Acta Neurochir 1993;125:41-6.
28. Nakasu S, Nakajima M, Matsumura K, Nakasu Y, Handa J. Meningioma: proliferating potential and clinicoradiological features. Neurosurgery 1995;37:1049-55.
29. Nakasu S, Nakasu Y, Nakajima M, Yokoyama M, Matsura M, Handa J. Potential doubling time and tumor doubling time in meningiomas and neurinomas. Acta Neurochir 1996;138:763-70.
30. Mantle Re, Lach B, Delgado Mr, Baeesa S, Belanger G. Predicting the probability of meningiomas recurrence based on the quantity of peritumoral brain edema on cumputerized tomography scanning. J Neurosurg 1999;91:375-83.
31. Palma L, Celli P, Franco C, Cervoni L, Cantore G. Long-term prognosis for atypical and malignant meningiomas: a study of 7 surgical cases. J Neurosurg 1997;86:793-800.
32. Firsching RP, Fisher A, Peters R, Thun F, Klug N. Growth rate of incidental meningiomas. J Neurosurg 1990;73:545-7.
33. Kuratsu J, Kochi M, Ushio Y. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 2000;92:766-70.
34. Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J. Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 2000;68:25-18.
35. Yonoka Y, Fujii Y, Tanaka R. Growth of incidental meningiomas. Acta Neurochir 2000;142:507-11.
36. Jääskeläinen J, Haltia M, Laasonen E, Wahlström T, Valtonen S. The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 1985;24:165-72.
37. Kakinuma K, Tanaka R, Onda K, Takahashi H. Proliferative potential of recurrence intracranial meningiomas as evaluated by labelling indices of BudR and Ki-67, and tumour doubling time. Acta Neurochir 1998;140 26-32.
38. Shibuva M, Hoshino T, Ito S, Wacker MR, Prados MD, Davis RL et al. Meningiomas: clinical implication of a high proliferative potential determined by Bromodeoxyuridine labeling. Neurosurgery 1992;30:494-8.
39. Sanson M, Cornu P. Biology of meningiomas. Acta Neurochir 2000;142:493-505.
40. Siegers HP, Zuber P, Hamou MF, van Melle GD, de Tribolet N. The implications of the heterogeneous distribution of Ki-67 labelled cells in meningiomas. Br J Neurosurg 1989;3:101-7.
41. Moller ML, Braendstrup O. No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry. J Neuroncol 1997;34:241-6.